NLRP3 and familial dilated cardiomyopathy: Metformin, which is a first-line antidiabetic drug, ameliorates DCM by regulating glycolipid metabolism, reducing AGE generation, inhibiting the NLRP3 inflammasome, and improving mitochondrial function, resulting in a cardioprotective effect [44, 76].